Search Clinical Trials
598,193 trials
ID
Status
Phase
Title
Sponsor
NCT07763938
CD19/CD20 Dual-Target in Vivo CAR-T Lentiviral Product in the Treatment of Relapsed/Refractory B-cell MalignanciesNanjing Legend Biotech Co.Not Yet RecruitingPhase 1
NCT07763938Not Yet Recruiting
Phase 1
CD19/CD20 Dual-Target in Vivo CAR-T Lentiviral Product in the Treatment of Relap...Nanjing Legend Biotech Co...
NCT07762300
Hybrid Transobturator Tape Versus Conventional Synthetic Tape for Stress Urinary IncontinenceBenha UniversityRecruitingNot Applicable
NCT07762300Recruiting
Not Applicable
Hybrid Transobturator Tape Versus Conventional Synthetic Tape for Stress Urinary...Benha University
NCT07763444
The Impact of Experiential Simulation on Nursing StudentsNecmettin Erbakan UniversityCompletedNot Applicable
NCT07763444Completed
Not Applicable
The Impact of Experiential Simulation on Nursing StudentsNecmettin Erbakan Univers...
NCT07763821
Clinical Utility of Serum Ribonuclease 1(RNASE1) as a Biomarker of Lupus Nephritis.Assiut UniversityNot Yet Recruiting
NCT07763821Not Yet Recruiting
—
Clinical Utility of Serum Ribonuclease 1(RNASE1) as a Biomarker of Lupus Nephrit...Assiut University
NCT07763314
Trends and Short-term Outcomes of Surgically Resected Early-onset Colorectal Cancer in Switzerland Between 2003 and 2022Cantonal Hospital of St. GallenCompleted
NCT07763314Completed
—
Trends and Short-term Outcomes of Surgically Resected Early-onset Colorectal Can...Cantonal Hospital of St....
NCT07763106
Effectiveness and Costs of Pressure Ulcer Treatment and the Quality of Life of Patients With Pressure Ulcers Receiving Home-Based and Institutional CareSalus Care Center, Rybnik, PolandNot Yet RecruitingNot Applicable
NCT07763106Not Yet Recruiting
Not Applicable
Effectiveness and Costs of Pressure Ulcer Treatment and the Quality of Life of P...Salus Care Center, Rybnik...
NCT07763496
Relacorilant and Nab-Paclitaxel in Recurrent or Metastatic Cervical CancerARCAGY/ GINECO GROUPNot Yet RecruitingPhase 2
NCT07763496Not Yet Recruiting
Phase 2
Relacorilant and Nab-Paclitaxel in Recurrent or Metastatic Cervical CancerARCAGY/ GINECO GROUP
NCT07763392
Establishing Normal Cognitive Test Scores for Adults Using a Voice-Enabled Digital Testing Platform Across the LifespanIntraneuronRecruiting
NCT07763392Recruiting
—
Establishing Normal Cognitive Test Scores for Adults Using a Voice-Enabled Digit...Intraneuron
NCT07762092
A Post Authorization Registry Study of Participants Treated With LEQEMBIEisai LimitedNot Yet Recruiting
NCT07762092Not Yet Recruiting
—
A Post Authorization Registry Study of Participants Treated With LEQEMBIEisai Limited
NCT07764081
Progression, Management, and Clinical Outcomes of Coronary Artery AneurysmsNanjing First Hospital, Nanjing Medical UniversityRecruiting
NCT07764081Recruiting
—
Progression, Management, and Clinical Outcomes of Coronary Artery AneurysmsNanjing First Hospital, N...
NCT07763704
The Impact of Tonsillectomy Techniques on Secondary Tonsillectomy BleedingAssiut UniversityNot Yet Recruiting
NCT07763704Not Yet Recruiting
—
The Impact of Tonsillectomy Techniques on Secondary Tonsillectomy BleedingAssiut University
NCT07762911
Evaluation of an MRI-based Prostate Cancer Screening Program (VISIONING): 5-Year Follow-up Round (VISIONING III)University Hospital, Basel, SwitzerlandRecruitingNot Applicable
NCT07762911Recruiting
Not Applicable
Evaluation of an MRI-based Prostate Cancer Screening Program (VISIONING): 5-Year...University Hospital, Base...
NCT07764172
Sarcopenia in Acute Ischemic StrokeUniversity Clinical Hospital na V.V.Vinogradov (branch of RUDN university na Patrice Lumumba)Recruiting
NCT07762586
Luminal Bladder Cancer Effective Response to Neoadjuvant Chemotherapy (LUMBER-NAC)Rutgers, The State University of New JerseyRecruitingPhase 2
NCT07762586Recruiting
Phase 2
Luminal Bladder Cancer Effective Response to Neoadjuvant Chemotherapy (LUMBER-NA...Rutgers, The State Univer...
NCT07762547
Evaluating Antiplatelet and Physical Therapy for Slowing Progression in Mild Moyamoya Disease.Beijing Tiantan HospitalNot Yet RecruitingNot Applicable
NCT07762547Not Yet Recruiting
Not Applicable
Evaluating Antiplatelet and Physical Therapy for Slowing Progression in Mild Moy...Beijing Tiantan Hospital
NCT07763093
Vertically Coronally Advanced Flap Versus Coronally Advanced Flap for Miller Class I Gingival RecessionUniversity of Medicine and Pharmacy at Ho Chi Minh CityActive Not RecruitingNot Applicable
NCT07763093Active Not Recruiting
Not Applicable
Vertically Coronally Advanced Flap Versus Coronally Advanced Flap for Miller Cla...University of Medicine an...
NCT07762755
Icosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CTBeijing Anzhen HospitalNot Yet RecruitingPhase 4
NCT07762755Not Yet Recruiting
Phase 4
Icosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CTBeijing Anzhen Hospital
NCT07764055
A Trial of Absorbable Regenerated Oxidized Cellulose for Surgical Hemostasis)Medprin Regenerative Medical Technologies Co., Ltd.CompletedPhase 3
NCT07764055Completed
Phase 3
A Trial of Absorbable Regenerated Oxidized Cellulose for Surgical Hemostasis)Medprin Regenerative Medi...
NCT07762768
Effect of CSIR-Developed High-Protein, Low-Glycaemic Index Rice on Glycaemic Response in Individuals With PrediabetesCSIR National Institute for Interdisciplinary Science and Technology (NIIST), ThiruvananthapuramNot Yet RecruitingNot Applicable
NCT07762768Not Yet Recruiting
Not Applicable
Effect of CSIR-Developed High-Protein, Low-Glycaemic Index Rice on Glycaemic Res...CSIR National Institute f...
NCT07763054
Low-dose Liposomal Amphotericin B for Antifungal Prophylaxis in Prolonged Neutropenia PatientsHaikou Affiliated Hospital of Central South University Xiangya School of MedicineRecruiting
NCT07763054Recruiting
—
Low-dose Liposomal Amphotericin B for Antifungal Prophylaxis in Prolonged Neutro...Haikou Affiliated Hospita...
Result Breakdown
Not yet recruiting9 (45%)
Recruiting7 (35%)
Completed3 (15%)
Active, not recruiting1 (5%)
Not Specified8 (40%)
not_applicable7 (35%)
Phase 22 (10%)
Phase 11 (5%)
Phase 41 (5%)
Phase 31 (5%)